The Management of Cardiometabolic Risk in MAFLD: Therapeutic Strategies to Modulate Deranged Metabolism and Cholesterol Levels
<i>Background and Objectives:</i> Fatty Liver Disease is a major health problem worldwide. We can distinguish liver steatosis as non-associated or associated with chronic/acute alcohol consumption. These two entities share similar stages ranging from hepatic fat storage (namely, steatosi...
Saved in:
| Main Authors: | Annalisa Pezzoli, Ludovico Abenavoli, Marialaura Scarcella, Carlo Rasetti, Gianluca Svegliati Baroni, Jan Tack, Emidio Scarpellini |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Medicina |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1648-9144/61/3/387 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diet, oxidative stress and MAFLD: a mini review
by: Zenan Hu, et al.
Published: (2025-03-01) -
Editorial: Nutriomic analysis of food and functional compounds for MAFLD prevention
by: Fermin I. Milagro, et al.
Published: (2025-08-01) -
A Scientometric Assessment of MAFLD in Children and Adolescents from 2007–2024
by: Raju Vaishya, et al.
Published: (2025-07-01) -
MAFLD - a new approach to fatty liver disease
by: Borys Łozowski, et al.
Published: (2025-05-01) -
Statin Monotherapy Not Inferior to Aspirin or Combined Aspirin and Statins Reducing the Incidences of Cirrhosis, HCC, and Mortality in MAFLD/MASH Patients: A Population Cohort Study
by: Lee CH, et al.
Published: (2024-12-01)